To participate in the MintHealth Security Token Offering Regulation D, please address your request to email@example.com and indicate the currency and amount you’d like to contribute (the minimum is 10,000 USD).
There is a $10,000 USD minimum per investor during the Regulation D Offering. You must also be an accredited investor. To learn more about being an accredited investor, click here.
Which payment methods will be accepted in the MintHealth Security Token Offering?
ETH (Ethereum), Bitcoin (Bitcoin) and USD will be the only method of payment accepted. If you would like to purchase using other coins, please use the ShapeShift web plugin.
The hard cap for the MintHealth Security Token sale is $23.5M USD (including maximum $1.07M USD raised during the Crowdfunding). There is no soft cap.
MintHealth Vidamints™ (VIDA) will operate as the rewards and incentive system on the MintHealth platform where Patients will earn VIDA as a reward for completing healthy activities. Patients will then be able to redeem VIDA for rewards in a similar fashion to frequent flier miles or other loyalty program point systems. In this case, the purchaser of the Vidamints will be insurance companies, corporate wellness programs, and any other entity that takes on the financial risk in caring for patients with diseases like obesity, diabetes, hypertension, among many other preventable chronic conditions. The VIDA token will not be used for capital raising. It will be a loyalty/utility token that is sold at a fixed price and will be tracked and transparent via the Blockchain.
The MHST token will entitle holders to i) a 10% royalty percentage of revenues generated through the sale of VIDA by MintHealth and ii) equity ownership in MintHealth. This structure provides a unique balance of participation in ecosystem growth and an equity ownership stake in MintHealth as a company.
Pilot programs with established partner organizations (See whitepaper section 3.8 for more on our partners) will drive initial adoption of Vidamints. By leveraging existing patient engagement platforms provided by MD Revolution, Inc., the MintHealth Platform will drive down healthcare costs of managing patients with or at risk for complications from chronic conditions (hospitalizations, emergency room visits, etc.). This would reduce the quantity and dollar amount of patient insurance reimbursement claims, ultimately reducing costs for Payers. Thus, these Payers have significant incentives to invest in an ecosystem such as MintHealth and purchase the Vidamint Token. Notably, the MD Revolution CCM platform has already demonstrated its capability to reduce healthcare costs at a 5x ROI for Payers in a chronic disease population.
Consumer 3rd party app companies (e.g. Fitbit, Diet Management, General Wellness, etc.) can provide VIDA to tokenize consumer behaviors of their respective user communities in order to:
Strengthen loyalty and retention of 3rd party developer end-user communities;
Provide app end-user access to a rich and diverse redemption marketplace of healthful products and services;
Provide a self-sovereign health record and history;
Facilitate access to end-user population behavior and outcomes analytics.
When a patient uses the MintHealth platform, he or she will receive rewards for being proactive about improving his or her health. Similar to an airline or debit/credit card reward program, patients and Providers will receive “status” benefits based on the total number of VIDA Tokens earned in a given year. Examples of such benefits include:
Discounts on insurance premiums
Discounts on co-pays, deductibles, and out-of-pocket expenses
Discounts on good and services provided by partner companies (e.g. pharmacies, physical therapy providers, spas, nutrition stores, etc.)
Access to special benefits (e.g. events, app features, exercise classes, merchandise, etc.)
Yes, there will be a 1 year lock-up for US investors and 4 months lock-up for non-US investors.
The MintHealth Tokens to be offered in an offering under Regulation D promulgated under the Securities Act have not been, and will not be, registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. These securities are expected to be offered and sold in reliance on the exemption from registration set forth in Section 506(c) under the Securities Act. In accordance therewith, you should be aware that (i) the securities may be sold only to “accredited investors,” which for natural persons are investors who meet certain minimum annual income or net worth thresholds; (ii) the securities will only be offered in reliance on an exemption from the registration requirements of the Securities Act and will not be required to comply with specific disclosure requirements that apply to registration under the Securities Act; (iii) the Securities and Exchange Commission will not pass upon the merits of or give its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials; (iv) the securities will be subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell their securities; investing in securities involves risk, and investors should be able to bear the loss of their investment; and (v) the securities offered will not be subject to the protections of the Investment Company Act.
Some of the statements herein may constitute forward-looking statements. These forward-looking statements may include, but are not limited to statements relating to our objectives, plans, and strategies; statements that contain projections of results of operations or financial condition or of stages of development of our products; statements relating to the research, development, and use of our products; and all statements (other than statements of historical facts) that address activities, events, or developments that we intend, expect,project, believe, or anticipate will or may occur in the future. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including, without limitation, regulatory risks, our ability to execute our business plan, and our ability to obtain financing on satisfactory terms, among other risk. The forward-looking statements included herein should not be regarded as a representation by MintHealth that the projected results will be achieved. We do not undertake any obligation to update any forward-looking statement.